Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Helicobacter ; 22(3)2017 Jun.
Article in English | MEDLINE | ID: mdl-28124467

ABSTRACT

BACKGROUND: Helicobacter (H.) suis is mainly associated with pigs, but is also the most prevalent gastric non-H. pylori Helicobacter species found in humans. Both H. pylori and H. suis may cause persistent infection of the stomach. Several immune evasion mechanisms have been proposed for H. pylori, which focus to a great extent on its major virulence factors, which are absent in H. suis. The aim of this study was to gain more knowledge on immune evasion by H. suis. MATERIALS AND METHODS: Cytokine expression kinetics were monitored in the stomach of BALB/c mice experimentally infected with H. suis. The cytokine expression profile in the stomach of naturally H. suis-infected pigs was also determined. Subsequently, the effect of H. suis on murine and porcine dendritic cell (DC) maturation and their ability to elicit T-cell effector responses was analyzed. RESULTS: Despite a Th17/Th2 response in the murine stomach, the inflammatory cell influx was unable to clear H. suis infection. H. suis-stimulated murine bone marrow-derived dendritic cells induced IL-17 secretion by CD4+ cells in vitro. Natural H. suis infection in pigs evoked increased expression levels of IL-17 mRNA in the antrum and IL-10 mRNA in the fundus. In contrast to mice, H. suis-stimulated porcine monocyte-derived dendritic cells were unable to express MHCII molecules on their cell surface. These semimature DCs induced proliferation of T-cells, which showed an increased expression of TGF-ß and FoxP3 mRNA levels. CONCLUSIONS: Helicobacter suis might evade host immune responses by skewing toward a Treg-biased response.


Subject(s)
Helicobacter Infections/veterinary , Helicobacter heilmannii/immunology , Host-Pathogen Interactions , Immune Evasion , Animals , Cytokines/metabolism , Female , Gene Expression Profiling , Helicobacter Infections/immunology , Helicobacter Infections/microbiology , Mice, Inbred BALB C , Stomach/immunology , Stomach/microbiology , Swine , T-Lymphocytes/immunology
2.
PLoS One ; 10(6): e0131364, 2015.
Article in English | MEDLINE | ID: mdl-26115373

ABSTRACT

Helicobacter suis (H. suis) is a widespread porcine gastric pathogen, which is also of zoonotic importance. The first goal of this study was to investigate the efficacy of several vaccine adjuvants (CpG-DNA, Curdlan, Freund's Complete and Incomplete, Cholera toxin), administered either subcutaneously or intranasally along with H. suis whole-cell lysate, to protect against subsequent H. suis challenge in a BALB/c infection model. Subcutaneous immunization with Freund's complete (FC)/lysate and intranasal immunization with Cholera toxin (CT)/lysate were shown to be the best options for vaccination against H. suis, as determined by the amount of colonizing H. suis bacteria in the stomach, although adverse effects such as post-immunization gastritis/pseudo-pyloric metaplasia and increased mortality were observed, respectively. Therefore, we decided to test alternative strategies, including sublingual vaccine administration, to reduce the unwanted side-effects. A CCR4 antagonist that transiently inhibits the migration of regulatory T cells was also included as a new adjuvant in this second study. Results confirmed that immunization with CT (intranasally or sublingually) is among the most effective vaccination protocols, but increased mortality was still observed. In the groups immunized subcutaneously with FC/lysate and CCR4 antagonist/lysate, a significant protection was observed. Compared to the FC/lysate immunized group, gastric pseudo-pyloric metaplasia was less severe or even absent in the CCR4 antagonist/lysate immunized group. In general, an inverse correlation was observed between IFN-γ, IL-4, IL-17, KC, MIP-2 and LIX mRNA expression and H. suis colonization density, whereas lower IL-10 expression levels were observed in partially protected animals.


Subject(s)
Adjuvants, Immunologic , Bacterial Vaccines , Helicobacter Infections , Helicobacter heilmannii/immunology , Receptors, CCR4/antagonists & inhibitors , Vaccination , Adjuvants, Immunologic/adverse effects , Adjuvants, Immunologic/pharmacology , Animals , Bacterial Vaccines/adverse effects , Bacterial Vaccines/immunology , Bacterial Vaccines/pharmacology , Cell Movement/drug effects , Cell Movement/immunology , Cytokines/immunology , Female , Helicobacter Infections/immunology , Helicobacter Infections/pathology , Helicobacter Infections/prevention & control , Mice , Mice, Inbred BALB C , Receptors, CCR4/immunology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/pathology
3.
Crit Rev Microbiol ; 38(1): 17-29, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21995731

ABSTRACT

Campylobacter enteritis is the most reported zoonotic disease in many developed countries where it imposes a serious health burden. Campylobacter transmission to humans occurs primarily through the chicken vector. Chicks are regarded as a natural host for Campylobacter species and are colonized with C. jejuni in particular. But despite carrying a very high bacterial load in their gastrointestinal tract, these birds, in contrast to humans, do not develop pathological signs. It seems that in chickens C. jejuni principally harbors in the cecal mucosal crypts, where an inefficient inflammatory response fails to clear the bacterium from the gut. Recent intensive research resulted in an increased insight into the cross talk between C. jejuni and its avian host. This review discusses the chicken intestinal mucosal immune response upon C. jejuni entrance, leading to tolerance and persistent cecal colonization. It might in addition provide a solid base for further research regarding this topic aiming to fully understand the host-bacterium dynamics of C. jejuni in chicks and to develop effective control measures to clear this zoonotic pathogen from poultry lines.


Subject(s)
Campylobacter Infections/veterinary , Campylobacter jejuni/growth & development , Chickens/immunology , Gastrointestinal Tract/immunology , Gastrointestinal Tract/microbiology , Poultry Diseases/microbiology , Animals , Campylobacter Infections/immunology , Campylobacter Infections/microbiology , Campylobacter jejuni/immunology , Chickens/microbiology , Immunity, Mucosal , Poultry Diseases/immunology
4.
Vector Borne Zoonotic Dis ; 12(2): 89-98, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22133236

ABSTRACT

Campylobacteriosis is the most reported foodborne gastroenteritic disease and poses a serious health burden in industrialized countries. Disease in humans is mainly caused by the zoonotic pathogen Campylobacter jejuni. Due to its wide-spread occurrence in the environment, the epidemiology of Campylobacter remains poorly understood. It is generally accepted, however, that chickens are a natural host for Campylobacter jejuni, and for Campylobacter spp. in general, and that colonized broiler chicks are the primary vector for transmitting this pathogen to humans. Several potential sources and vectors for transmitting C. jejuni to broiler flocks have been identified. Initially, one or a few broilers can become colonized at an age of >2 weeks until the end of rearing, after which the infection will rapidly spread throughout the entire flock. Such a flock is generally colonized until slaughter and infected birds carry a very high C. jejuni load in their gastrointestinal tract, especially the ceca. This eventually results in contaminated carcasses during processing, which can transmit this pathogen to humans. Recent genetic typing studies showed that chicken isolates can frequently be linked to human clinical cases of Campylobacter enteritis. However, despite the increasing evidence that the chicken reservoir is the number one risk factor for disease in humans, no effective strategy exists to reduce Campylobachter prevalence in poultry flocks, which can in part be explained by the incomplete understanding of the epidemiology of C. jejuni in broiler flocks. As a result, the number of human campylobacteriosis cases associated with the chicken vector remains strikingly high.


Subject(s)
Campylobacter Infections/microbiology , Campylobacter Infections/transmission , Campylobacter jejuni/pathogenicity , Chickens/microbiology , Disease Reservoirs/microbiology , Animals , Disease Vectors , Food Microbiology , Gastroenteritis/microbiology , Humans , Poultry , Poultry Diseases/microbiology , Risk Factors , Zoonoses/microbiology , Zoonoses/transmission
5.
Vet Res ; 42: 118, 2011 Dec 07.
Article in English | MEDLINE | ID: mdl-22151081

ABSTRACT

Salmonella Typhimurium infections in pigs often result in the development of carriers that intermittently excrete Salmonella in very low numbers. During periods of stress, for example transport to the slaughterhouse, recrudescence of Salmonella may occur, but the mechanism of this stress related recrudescence is poorly understood. Therefore, the aim of the present study was to determine the role of the stress hormone cortisol in Salmonella recrudescence by pigs. We showed that a 24 h feed withdrawal increases the intestinal Salmonella Typhimurium load in pigs, which is correlated with increased serum cortisol levels. A second in vivo trial demonstrated that stress related recrudescence of Salmonella Typhimurium in pigs can be induced by intramuscular injection of dexamethasone. Furthermore, we found that cortisol, but not epinephrine, norepinephrine and dopamine, promotes intracellular proliferation of Salmonella Typhimurium in primary porcine alveolar macrophages, but not in intestinal epithelial cells and a transformed cell line of porcine alveolar macrophages. A microarray based transcriptomic analysis revealed that cortisol did not directly affect the growth or the gene expression or Salmonella Typhimurium in a rich medium, which implies that the enhanced intracellular proliferation of the bacterium is probably caused by an indirect effect through the cell. These results highlight the role of cortisol in the recrudescence of Salmonella Typhimurium by pigs and they provide new evidence for the role of microbial endocrinology in host-pathogen interactions.


Subject(s)
Epithelial Cells/metabolism , Gene Expression Regulation, Bacterial , Hydrocortisone/metabolism , Macrophages, Alveolar/metabolism , Salmonella Infections, Animal/microbiology , Salmonella typhimurium/genetics , Swine Diseases/microbiology , Animals , Bacterial Load/veterinary , Cell Line , Cell Proliferation , Colony Count, Microbial/veterinary , Enzyme-Linked Immunosorbent Assay/veterinary , Epithelial Cells/microbiology , Hydrocortisone/blood , Intestinal Mucosa/metabolism , Intestines/microbiology , Macrophages, Alveolar/microbiology , Salmonella typhimurium/metabolism , Stress, Physiological , Swine
6.
J Food Prot ; 74(10): 1729-34, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22004822

ABSTRACT

Campylobacter jejuni is the most common bacterial cause of diarrheal disease in humans worldwide, with poultry products being a major source. Therefore, strategies to decrease Campylobacter colonization during primary production might aid in reducing the number of human campylobacteriosis cases. Several plant-derived compounds have been reported to possess anti-Campylobacter properties in vitro, so they could be promising candidates to reduce Campylobacter colonization in broiler chickens. To test this hypothesis, selected plant-derived antimicrobials (caffeic, gallic, protocatechuic, and vanillic acids, epigallocatechin gallate, trans-cinnamaldehyde, and thymol) were screened for anti-Campylobacter activity by determining MICs and setting up time-kill curves for C. jejuni strain KC 40. These experiments revealed marked antibacterial activity, especially for the cinnamon oil ingredient trans-cinnamaldehyde (CIN). This compound was tested in a broiler chick seeder model; it was added to the feed in coated form at an effective concentration of 0.3 % from day-of-hatch for the entire 22-day duration of the experiment. At 14 days of age, one-third of the birds were inoculated with C. jejuni strain KC 40 and served as seeders. CIN was not able to reduce cecal Campylobacter colonization in this model, which was confirmed in a cecal loop experiment. Despite CIN concentrations much higher than the MIC, C. jejuni numbers were not reduced compared with those in nontreated ceca at 2 and 24 h after injection. In conclusion, this study shows a marked discrepancy between in vitro and in vivo activity of CIN against C. jejuni strain KC 40.


Subject(s)
Acrolein/analogs & derivatives , Anti-Bacterial Agents/pharmacology , Campylobacter Infections/prevention & control , Campylobacter jejuni/drug effects , Chickens/microbiology , Acrolein/pharmacology , Animals , Campylobacter Infections/microbiology , Campylobacter Infections/veterinary , Campylobacter jejuni/growth & development , Cecum/microbiology , Dose-Response Relationship, Drug , Flavoring Agents/pharmacology , Humans , Microbial Sensitivity Tests , Poultry Diseases/microbiology , Poultry Diseases/prevention & control
7.
PLoS One ; 6(8): e23871, 2011.
Article in English | MEDLINE | ID: mdl-21909370

ABSTRACT

BACKGROUND AND AIMS: Both deoxynivalenol (DON) and nontyphoidal salmonellosis are emerging threats with possible hazardous effects on both human and animal health. The objective of this study was to examine whether DON at low but relevant concentrations interacts with the intestinal inflammation induced by Salmonella Typhimurium. METHODOLOGY: By using a porcine intestinal ileal loop model, we investigated whether intake of low concentrations of DON interacts with the early intestinal inflammatory response induced by Salmonella Typhimurium. RESULTS: A significant higher expression of IL-12 and TNFα and a clear potentiation of the expression of IL-1ß, IL-8, MCP-1 and IL-6 was seen in loops co-exposed to 1 µg/mL of DON and Salmonella Typhimurium compared to loops exposed to Salmonella Typhimurium alone. This potentiation coincided with a significantly enhanced Salmonella invasion in and translocation over the intestinal epithelial IPEC-J2 cells, exposed to non-cytotoxic concentrations of DON for 24 h. Exposure of Salmonella Typhimurium to 0.250 µg/mL of DON affected the bacterial gene expression level of a limited number of genes, however none of these expression changes seemed to give an explanation for the increased invasion and translocation of Salmonella Typhimurium and the potentiated inflammatory response in combination with DON. CONCLUSION: These data imply that the intake of low and relevant concentrations of DON renders the intestinal epithelium more susceptible to Salmonella Typhimurium with a subsequent potentiation of the inflammatory response in the gut.


Subject(s)
Ileum/microbiology , Ileum/pathology , Inflammation/microbiology , Inflammation/pathology , Mycotoxins/toxicity , Salmonella typhimurium/physiology , Trichothecenes/toxicity , Animals , Cell Differentiation/drug effects , Cell Line , Disease Models, Animal , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Epithelial Cells/pathology , Gene Expression Regulation, Bacterial/drug effects , Humans , Ileum/drug effects , Intestinal Mucosa/drug effects , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Salmonella typhimurium/cytology , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Sus scrofa
8.
Cell Microbiol ; 13(12): 1933-55, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21899697

ABSTRACT

Helicobacter (H.) suis is the most prevalent non-H. pylori Helicobacter species colonizing the stomach of humans suffering from gastric disease. In the present study, we aimed to unravel the mechanism used by H. suis to induce gastric epithelial cell damage. H. suis lysate induced mainly apoptotic death of human gastric epithelial cells. Inhibition of γ-glutamyl transpeptidase (GGT) activity present in H. suis lysate and incubation of AGS cells with purified native and recombinant H. suis GGT showed that this enzyme was partly responsible for the observed apoptosis. Supplementation of H. suis or H. pylori GGT-treated cells with glutathione strongly enhanced the harmful effect of both enzymes and resulted in the induction of oncosis/necrosis, demonstrating that H. suis and H. pylori GGT-mediated degradation of glutathione and the resulting formation of glutathione degradation products play a direct and active role in the induction of gastric epithelial cell death. This was preceded by an increase of extracellular H(2)O(2) concentrations, generated in a cell-independent manner and causing lipid peroxidation. In conclusion, H. suis and H. pylori GGT-mediated generation of pro-oxidant glutathione degradation products brings on cell damage and causes apoptosis or necrosis, dependent on the amount of extracellular glutathione available as a GGT substrate.


Subject(s)
Epithelial Cells/microbiology , Glutathione/metabolism , Helicobacter Infections/microbiology , Helicobacter/pathogenicity , gamma-Glutamyltransferase/metabolism , Amino Acid Sequence , Bacterial Proteins/metabolism , Cell Death , Cell Line, Tumor , Enzyme Activation , Enzyme Assays , Escherichia coli/genetics , Escherichia coli/metabolism , Flow Cytometry , Gastric Mucosa/metabolism , Helicobacter/drug effects , Helicobacter/enzymology , Helicobacter/genetics , Humans , Hydrogen Peroxide/metabolism , Isoxazoles/pharmacology , Lipid Peroxidation , Membrane Potential, Mitochondrial , Molecular Sequence Data , Recombinant Proteins/metabolism , Stomach/microbiology , gamma-Glutamyltransferase/antagonists & inhibitors , gamma-Glutamyltransferase/isolation & purification
9.
Vet Microbiol ; 153(3-4): 339-42, 2011 Dec 15.
Article in English | MEDLINE | ID: mdl-21733643

ABSTRACT

Helicobacter suis is a very fastidious porcine gastric pathogen, which is also considered to be of zoonotic importance. In vitro antimicrobial susceptibility cannot be determined using standard assays, as this agent only grows in a biphasic medium with an acidic pH. Therefore, a combined agar and broth dilution method was used to analyse the activity of nine antimicrobial agents against nine H. suis isolates. After 48 h microaerobic incubation, minimal inhibitory concentrations (MICs) were determined by software-assisted calculation of bacterial growth. Only for enrofloxacin a bimodal distribution of MICs was demonstrated, indicating acquired resistance in one strain, which showed an AGT→AGG (Ser→Arg) substitution at codon 99 of gyrA. In conclusion, the assay developed here is suitable for determination of the antimicrobial susceptibility of H. suis isolates, although activity of acid sensitive antimicrobial agents may be higher than predicted from MIC endpoints.


Subject(s)
Anti-Infective Agents/pharmacology , Helicobacter heilmannii/drug effects , Animals , Drug Resistance, Bacterial , Enrofloxacin , Fluoroquinolones/pharmacology , Helicobacter heilmannii/genetics , Helicobacter heilmannii/isolation & purification , Microbial Sensitivity Tests , Swine
10.
Vet Res ; 42: 82, 2011 Jun 29.
Article in English | MEDLINE | ID: mdl-21714866

ABSTRACT

Campylobacter contaminated broiler chicken meat is an important source of foodborne gastroenteritis and poses a serious health burden in industrialized countries. Broiler chickens are commonly regarded as a natural host for this zoonotic pathogen and infected birds carry a very high C. jejuni load in their gastrointestinal tract, especially the ceca. This eventually results in contaminated carcasses during processing. Current intervention methods fail to reduce the colonization of broiler chicks by C. jejuni due to an incomplete understanding on the interaction between C. jejuni and its avian host. Clearly, C. jejuni developed several survival and colonization mechanisms which are responsible for its highly adapted nature to the chicken host. But how these mechanisms interact with one another, leading to persistent, high-level cecal colonization remains largely obscure. A plethora of mutagenesis studies in the past few years resulted in the identification of several of the genes and proteins of C. jejuni involved in different aspects of the cellular response of this bacterium in the chicken gut. In this review, a thorough, up-to-date overview will be given of the survival mechanisms and colonization factors of C. jejuni identified to date. These factors may contribute to our understanding on how C. jejuni survival and colonization in chicks is mediated, as well as provide potential targets for effective subunit vaccine development.


Subject(s)
Bacterial Adhesion , Campylobacter Infections/veterinary , Campylobacter jejuni/physiology , Chickens , Gastrointestinal Tract/microbiology , Poultry Diseases/microbiology , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Campylobacter Infections/immunology , Campylobacter Infections/microbiology , Poultry Diseases/immunology
11.
Vet Microbiol ; 152(3-4): 219-28, 2011 Sep 28.
Article in English | MEDLINE | ID: mdl-21482043

ABSTRACT

Campylobacter-contaminated poultry meat is an important source of foodborne gastroenteritis and poses a serious health burden in industrialized countries. Broiler chickens are commonly regarded as a natural host for this pathogen and infected birds carry a very high Campylobacter load in their gastrointestinal tract, especially the ceca. This results in contaminated carcasses during processing. While hygienic measures at the farm and control measures during carcass processing can have some effect on the reduction of Campylobacter numbers on the retail product, intervention at the farm level by reducing colonization of the ceca should be taken into account in the overall control policy. This review gives an up-to-date overview of suggested on-farm control measures to reduce the prevalence and colonization of Campylobacter in poultry.


Subject(s)
Campylobacter Infections/prevention & control , Campylobacter Infections/veterinary , Campylobacter , Meat/microbiology , Poultry Diseases/prevention & control , Animal Husbandry , Animals , Bacterial Vaccines/administration & dosage , Campylobacter Infections/epidemiology , Campylobacter Infections/microbiology , Chickens , Humans , Poultry , Poultry Diseases/epidemiology , Poultry Diseases/microbiology , Probiotics/administration & dosage
12.
PLoS One ; 5(11): e14083, 2010 Nov 22.
Article in English | MEDLINE | ID: mdl-21124878

ABSTRACT

BACKGROUND: "Helicobacter (H.) heilmannii" type 1 is the most prevalent gastric non-H. pylori Helicobacter species in humans suffering from gastric disease. It has been shown to be identical to H. suis, a bacterium which is mainly associated with pigs. To obtain better insights into the long-term pathogenesis of infections with this micro-organism, experimental infections were carried out in different rodent models. METHODOLOGY/PRINCIPAL FINDINGS: Mongolian gerbils and mice of two strains (BALB/c and C57BL/6) were infected with H. suis and sacrificed at 3 weeks, 9 weeks and 8 months after infection. Gastric tissue samples were collected for PCR analysis, histological and ultrastructural examination. In gerbils, bacteria mainly colonized the antrum and a narrow zone in the fundus near the forestomach/stomach transition zone. In both mice strains, bacteria colonized the entire glandular stomach. Colonization with H. suis was associated with necrosis of parietal cells in all three animal strains. From 9 weeks after infection onwards, an increased proliferation rate of mucosal epithelial cells was detected in the stomach regions colonized with H. suis. Most gerbils showed a marked lymphocytic infiltration in the antrum and in the forestomach/stomach transition zone, becoming more pronounced in the course of time. At 8 months post infection, severe destruction of the normal antral architecture at the inflamed sites and development of mucosa-associated lymphoid tissue (MALT) lymphoma-like lesions were observed in some gerbils. In mice, the inflammatory response was less pronounced than in gerbils, consisting mainly of mononuclear cell infiltration and being most severe in the fundus. CONCLUSIONS/SIGNIFICANCE: H. suis causes death of parietal cells, epithelial cell hyperproliferation and severe inflammation in mice and Mongolian gerbil models of human gastric disease. Moreover, MALT lymphoma-like lesions were induced in H. suis-infected Mongolian gerbils. Therefore, the possible involvement of this micro-organism in human gastric disease should not be neglected.


Subject(s)
Gastric Mucosa/microbiology , Helicobacter heilmannii/physiology , Stomach Diseases/microbiology , Stomach/microbiology , Animals , Cell Proliferation , Disease Models, Animal , Gastric Mucosa/pathology , Gastric Mucosa/ultrastructure , Gerbillinae , Germinal Center/microbiology , Germinal Center/pathology , H(+)-K(+)-Exchanging ATPase/metabolism , Host-Pathogen Interactions , Humans , Immunohistochemistry , Lymphoma, B-Cell, Marginal Zone/etiology , Lymphoma, B-Cell, Marginal Zone/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Microscopy, Electron, Transmission , Parietal Cells, Gastric/metabolism , Parietal Cells, Gastric/microbiology , Parietal Cells, Gastric/pathology , Species Specificity , Stomach/pathology , Stomach Diseases/complications , Stomach Diseases/pathology
13.
Avian Pathol ; 37(4): 379-83, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18622853

ABSTRACT

The usefulness of butyrate, acetate, propionate and l-lactate for the control of Campylobacter jejuni infections in broilers was assessed. For this purpose, the effect of these acids on the growth of C. jejuni in broth and intestinal mucous was determined, as well as their influence on the invasiveness of C. jejuni in intestinal epithelial cells. From these in vitro obtained results, one acid was retained for use as a feed additive in an in vivo trial. Butyrate was the most successful of the short-chain fatty acids, with 12.5 mM being bactericidal for C. jejuni at pH 6.0. Propionate and acetate had a bacteriostatic effect at 50 mM. None of the short-chain fatty acids had a bactericidal effect at pH 7.5 at a maximum concentration of 50 mM. Mucous increased the minimum bactericidal concentration of butyrate, but not the bacteriostatic concentrations of propionate or acetate. When C. jejuni was incubated in growth subinhibitory concentrations of butyrate, acetate or propionate or 25 mM L-lactate, no alteration in the invasive capabilities of C. jejuni in Caco-2 cells was observed. The addition of butyrate-coated micro-beads to the feed was unsuccessful to reduce C. jejuni caecal colonization in a seeder model using 2-week-old broilers. In conclusion, despite the marked bactericidal effect of butyrate towards C. jejuni in vitro, butyrate-coated micro-beads do not protect broilers from caecal colonization with C. jejuni in the applied test conditions. This might be partially ascribed to the protective effect of mucous and the rapid absorption of butyrate by the enterocytes.


Subject(s)
Campylobacter Infections/veterinary , Campylobacter jejuni/drug effects , Chickens , Epithelial Cells/microbiology , Fatty Acids/pharmacology , Lactic Acid/pharmacology , Animal Feed , Animals , Caco-2 Cells , Campylobacter Infections/prevention & control , Carrier State , Cecum/microbiology , Diet , Dietary Supplements , Dose-Response Relationship, Drug , Epithelial Cells/drug effects , Fatty Acids/administration & dosage , Humans , Intestinal Mucosa/cytology , Lactic Acid/administration & dosage , Microspheres
14.
Br J Nutr ; 100(3): 480-4, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18275629

ABSTRACT

Invasion in and translocation across enterocytes are major events during Campylobacter jejuni-induced enteritis in humans. C. jejuni in vitro infection of cell monolayers typically results in loss of tight junction integrity, which could contribute to translocation. In the present study, we wanted to investigate whether butyrate is able to confer protection to Caco-2 cells against C. jejuni invasion, thus reducing paracellular permeability and limiting C. jejuni translocation. Protection of Caco-2 cells against C. jejuni invasion was assessed using a gentamicin protection assay. Transwell systems were used to investigate the impact of butyrate on translocation of C. jejuni across a Caco-2 monolayer and its effect on transepithelial resistance during infection. Butyrate protected Caco-2 cells against C. jejuni invasion in a concentration-dependent manner. Differentiated Caco-2 cells were less susceptible to C. jejuni invasion than 3-d-old undifferentiated cells and higher concentrations of butyrate and longer incubation times were needed to become refractive for invasion. C. jejuni translocation over Caco-2 monolayers was reduced when monolayers were treated with butyrate and this was accompanied by an enhanced drop in transepithelial resistance. The present study showed that butyrate is able to protect Caco-2 cells from two major virulence mechanisms of C. jejuni, namely invasion and translocation, but not from a decline in transepithelial resistance.


Subject(s)
Butyrates/pharmacology , Campylobacter jejuni/physiology , Intestinal Mucosa/microbiology , Bacterial Adhesion/drug effects , Bacterial Translocation/drug effects , Caco-2 Cells , Campylobacter Infections/microbiology , Campylobacter Infections/prevention & control , Campylobacter jejuni/drug effects , Colonic Diseases/microbiology , Colonic Diseases/prevention & control , Colony Count, Microbial , Humans , Microbial Viability/drug effects
15.
Vet Microbiol ; 130(3-4): 285-97, 2008 Aug 25.
Article in English | MEDLINE | ID: mdl-18187272

ABSTRACT

Although poultry meat is now recognized as the main source of Campylobacter jejuni gastroenteritis, little is known about the strategy used by the bacterium to colonize the chicken intestinal tract. In this study, the mechanism of C. jejuni colonization in chickens was studied using four human and four poultry isolates of C. jejuni. The C. jejuni strains were able to invade chicken primary cecal epithelial crypt cells in a predominantly microtubule-dependent way (five out of eight strains). Invasion of cecal epithelial cells was not accompanied by necrosis or apoptosis in the cell cultures, nor by intestinal inflammation in a cecal loop model. C. jejuni from human origin displayed a similar invasive profile compared to the poultry isolates. Invasiveness of the strains in vitro correlated with the magnitude of spleen colonization in C. jejuni inoculated chicks. The C. jejuni bacteria that invaded the epithelial cells were not able to proliferate intracellularly, but quickly evaded from the cells. In contrast, the C. jejuni strains were capable of replication in chicken intestinal mucus. These findings suggest a novel colonization mechanism by escaping rapid mucosal clearance through short-term epithelial invasion and evasion, combined with fast replication in the mucus.


Subject(s)
Campylobacter Infections/veterinary , Campylobacter jejuni/physiology , Cecum/microbiology , Chickens , Poultry Diseases/microbiology , Animals , Bacterial Adhesion/physiology , Campylobacter Infections/microbiology , Carrier State , Cecum/cytology , Cells, Cultured , Epithelial Cells/microbiology , Fibroblasts/microbiology , Intestinal Mucosa/cytology , Microtubules/physiology , Specific Pathogen-Free Organisms
16.
J Med Microbiol ; 56(Pt 10): 1284-1289, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17893162

ABSTRACT

Campylobacter jejuni is one of the leading causes of food-borne gastroenteritis. Because of the high prevalence of C. jejuni in poultry, poultry meat is considered a major source of C. jejuni infections for humans. However, it is not known whether all poultry-associated C. jejuni strains are capable of causing disease in humans. Four different virulence properties of C. jejuni strains were compared between 20 poultry isolates and 24 human isolates. Strains were chosen based on their PFGE pattern to represent a heterogeneous population. The isolates were compared for their ability to invade and induce interleukin-8 (IL-8) production in T84 cells, their production of functional cytolethal distending toxin (CDT) using HEp-2 cells, and their sodium deoxycholate resistance. All four virulence factors were present among strains of human and poultry origin, with strong differences observed among strains. For invasion and IL-8 induction, no difference was observed between the two populations. However, on average, human isolates arrested more HEp-2 cells in their cell cycle than did the poultry isolates (P=0.041), suggesting higher CDT production by the former. The ability to survive 16 000 mug sodium deoxycholate ml(-1) was significantly more pronounced (P=0.006) among human isolates than poultry isolates, although all strains possessed the cmeABC operon. These data suggest that all four virulence properties are widespread among C. jejuni isolates, but that a higher degree of bile-salt resistance and more pronounced CDT production are associated with strains causing enteritis in humans.


Subject(s)
Campylobacter Infections/microbiology , Campylobacter Infections/veterinary , Campylobacter jejuni/isolation & purification , Campylobacter jejuni/pathogenicity , Poultry Diseases/microbiology , Animals , Anti-Bacterial Agents/pharmacology , Bacterial Toxins/biosynthesis , Cell Line, Tumor , Chickens , Deoxycholic Acid/pharmacology , Drug Resistance, Bacterial , Genes, Bacterial , Humans , Interleukin-8/biosynthesis , Operon , Poultry , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...